• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性高血压性心脏病导致的心力衰竭。

Heart Failure in Women Due to Hypertensive Heart Disease.

机构信息

Department of Medicine, Cardiology Division, U.S. Department of Veterans Affairs, VA Long Beach Healthcare System, 1 Hoag Drive, Newport Beach, CA 92663, USA.

Department of Medicine, Cardiology Division, Hoag Memorial Hospital, University of California, Irvine, Irvine, CA, USA.

出版信息

Heart Fail Clin. 2019 Oct;15(4):497-507. doi: 10.1016/j.hfc.2019.06.002. Epub 2019 Aug 2.

DOI:10.1016/j.hfc.2019.06.002
PMID:31472885
Abstract

Heart failure (HF) is a significant cause of cardiovascular morbidity and mortality for women in the United States. There are clear sex-specific differences between men and women in etiology, disease progression, and outcomes. HF with preserved ejection fraction is the most common type of HF in women, with hypertensive heart disease playing a pivotal role in its etiology. The Practice Guidelines do not endorse sex-specific recommendations for standard medical therapy of HF management. Women are underrepresented in HF clinical trials, leading to a lacking evidence base supporting sex-specific therapy. Further studies are needed to evaluate targeted HF therapies in women.

摘要

心力衰竭(HF)是美国女性心血管发病率和死亡率的重要原因。在病因、疾病进展和结局方面,男性和女性之间存在明显的性别特异性差异。射血分数保留的心力衰竭(HFpEF)是女性中最常见的心力衰竭类型,高血压性心脏病在其病因中起着关键作用。实践指南不支持针对 HF 管理的标准医学治疗的性别特异性建议。女性在 HF 临床试验中的代表性不足,导致缺乏支持性别特异性治疗的证据基础。需要进一步的研究来评估针对女性的 HF 靶向治疗。

相似文献

1
Heart Failure in Women Due to Hypertensive Heart Disease.女性高血压性心脏病导致的心力衰竭。
Heart Fail Clin. 2019 Oct;15(4):497-507. doi: 10.1016/j.hfc.2019.06.002. Epub 2019 Aug 2.
2
Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.射血分数保留或降低的急性失代偿性心力衰竭住院患者的心力衰竭病因及预后
Am J Cardiol. 2016 Dec 15;118(12):1881-1887. doi: 10.1016/j.amjcard.2016.08.080. Epub 2016 Sep 15.
3
Heart Failure in Women.女性心力衰竭
Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):216-223. doi: 10.14797/mdcj-13-4-216.
4
Heart Failure with Reduced Ejection Fraction in Women: Epidemiology, Outcomes, and Treatment.女性射血分数降低型心力衰竭:流行病学、结局和治疗。
Heart Fail Clin. 2019 Jan;15(1):19-27. doi: 10.1016/j.hfc.2018.08.003. Epub 2018 Oct 24.
5
Advanced heart failure and transplantation in women.女性晚期心力衰竭与心脏移植
Curr Cardiol Rep. 2005 May;7(3):184-9. doi: 10.1007/s11886-005-0075-6.
6
Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.射血分数降低和射血分数保留的急性失代偿性心力衰竭住院患者的性别差异。
Am Heart J. 2012 Mar;163(3):430-7, 437.e1-3. doi: 10.1016/j.ahj.2011.12.013.
7
Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial).性别并不影响射血分数降低的心力衰竭恶化住院患者的出院后结局(来自托伐普坦治疗心力衰竭结局试验:血管加压素拮抗剂的疗效[EVEREST]研究)。
Am J Cardiol. 2012 Dec 15;110(12):1803-8. doi: 10.1016/j.amjcard.2012.08.016. Epub 2012 Sep 19.
8
Primary Prevention of Heart Failure in Women.女性心力衰竭的一级预防。
JACC Heart Fail. 2019 Mar;7(3):181-191. doi: 10.1016/j.jchf.2019.01.011.
9
Sex, drugs, and heart failure: a sex-sensitive review of the evidence base behind current heart failure clinical guidelines.性、药物与心力衰竭:当前心力衰竭临床指南背后证据基础的性别敏感性回顾。
ESC Heart Fail. 2018 Oct;5(5):745-754. doi: 10.1002/ehf2.12307. Epub 2018 Jun 19.
10
Comparison of morbidity in women versus men with heart failure and preserved ejection fraction.射血分数保留的心力衰竭女性与男性的发病率比较。
Am J Cardiol. 2006 Apr 15;97(8):1228-31. doi: 10.1016/j.amjcard.2005.11.042. Epub 2006 Mar 2.

引用本文的文献

1
Sociodemographic and sex differences in the global burden of hypertensive heart disease, 1990-2021: a population-based analysis.1990 - 2021年全球高血压性心脏病负担的社会人口统计学和性别差异:基于人群的分析
Trop Med Health. 2025 Aug 14;53(1):108. doi: 10.1186/s41182-025-00791-9.
2
Gender Effect on Clinical Profiles, Pharmacological Treatments and Prognosis in Patients Hospitalized for Heart Failure.性别对因心力衰竭住院患者的临床特征、药物治疗及预后的影响
J Clin Med. 2024 Feb 2;13(3):881. doi: 10.3390/jcm13030881.
3
Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.
阿巴洛肽治疗绝经后骨质疏松症的心血管安全性:来自 ACTIVE 阶段 3 试验的分析。
J Clin Endocrinol Metab. 2020 Nov 1;105(11):3384-95. doi: 10.1210/clinem/dgaa450.
4
Cardioprotective Effects of Dietary Phytochemicals on Oxidative Stress in Heart Failure by a Sex-Gender-Oriented Point of View.从性别角度看膳食植物化学物对心力衰竭氧化应激的心脏保护作用。
Oxid Med Cell Longev. 2020 Jan 6;2020:2176728. doi: 10.1155/2020/2176728. eCollection 2020.